Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)

NCT00400153

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 1012.56.01006 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 1012.56.01051 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States
  • 1012.56.01071 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States
  • 1012.56.01039 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
View all 180 locations
View Trial Details
Completed

Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection

NCT01483625

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.479.01017 Boehringer Ingelheim Investigational Site Tucson, Arizona, United States
  • 205.479.01036 Boehringer Ingelheim Investigational Site Riverside, California, United States
  • 205.479.01024 Boehringer Ingelheim Investigational Site San Diego, California, United States
  • 205.479.01043 Boehringer Ingelheim Investigational Site DeLand, Florida, United States
View all 27 locations
View Trial Details
Completed

12 / 48 Week Pivotal PFT vs PBO in COPD I

NCT00782210

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 1222.11.1122 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States
  • 1222.11.1116 Boehringer Ingelheim Investigational Site Berkeley, California, United States
  • 1222.11.1121 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
  • 1222.11.1111 Boehringer Ingelheim Investigational Site Fort Collins, Colorado, United States
View all 54 locations
View Trial Details
Completed

Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD

NCT00535366

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 1249.1.32003 Boehringer Ingelheim Investigational Site Genk, Belgium
  • 1249.1.32001 Boehringer Ingelheim Investigational Site Ghent, Belgium
  • 1249.1.32002 Boehringer Ingelheim Investigational Site Hasselt, Belgium
  • 1249.1.32004 Boehringer Ingelheim Investigational Site Ostend, Belgium
View Trial Details
Completed

Assessment of Health-status of Patients With Chronic Obstructive Pulmonary Disease (COPD) on Maintenance Therapy With Spiriva HH Measured by COPD Assessment Test (CAT) Test

NCT01644734

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site 236 Andrychów, Poland
  • Boehringer Ingelheim Investigational Site 170 Bialystok, Poland
  • Boehringer Ingelheim Investigational Site 184 Bialystok, Poland
  • Boehringer Ingelheim Investigational Site 240 Bialystok, Poland
View all 247 locations
View Trial Details
Completed

Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).

NCT00523991

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 205.365.1003 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.365.1004 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 205.365.1098 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States
  • 205.365.1023 Boehringer Ingelheim Investigational Site Palo Alto, California, United States
View all 62 locations
View Trial Details
Completed

Tiotropium / Respimat One-Year Study

NCT00168844

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Los Angeles, California, United States
  • Boehringer Ingelheim Investigational Site Pismo Beach, California, United States
  • Boehringer Ingelheim Investigational Site San Diego, California, United States
  • Boehringer Ingelheim Investigational Site Fort Collins, Colorado, United States
View all 72 locations
View Trial Details
Completed

Tiotropium / Respimat One-Year Study

NCT00168831

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • Boehringer Ingelheim Investigational Site La Jolla, California, United States
  • Boehringer Ingelheim Investigational Site Long Beach, California, United States
  • Boehringer Ingelheim Investigational Site San Luis Obispo, California, United States
View all 76 locations
View Trial Details

Related conditions